Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 3/20 | 0.39 |
| ▸ | ITGA1 | P56199 | 1/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.39 |
| ▸ | NAT1 | P18440 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32690859 | 0.93 | MAP4K4 (0.46) | FFAR4FFAR1HSP90AA1HSP90AB1HSD17B2 | |
| SCHEMBL32690778 | 0.90 | HDAC6 (0.42) | FFAR4FFAR1ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL32690723 | 0.88 | POLB (0.44) | FFAR4ALDH1A1LMNASMN1; SMN2POLB | |
| SCHEMBL32690793 | 0.87 | HDAC1 (0.48) | — | |
| SCHEMBL32690703 | 0.86 | HDAC1 (0.48) | FFAR4FFAR1ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL32690861 | 0.86 | MAP4K4 (0.45) | FFAR4FFAR1HSD17B2ALDH1A1LMNA | |
| SCHEMBL32690710 | 0.85 | HDAC6 (0.48) | ALDH1A1LMNASMN1; SMN2POLBBRD4 | |
| SCHEMBL32690856 | 0.84 | HDAC1 (0.40) | BRD4 | |
| SCHEMBL32690841 | 0.84 | IDO1 (0.41) | FFAR4FFAR1HSP90AA1HSP90AB1ALDH1A1 | |
| SCHEMBL32690672 | 0.84 | PTGES (0.44) | LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085046-A1 | Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition | TAIWANJ PHARMACEUTICALS CO LTD (TW) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085046-A1 | Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition | NOX1, NOX4, CYBB | FFAR4 2446/4885FFAR1 1808/4885HSP90AA1 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.